Health Sciences Acquisitions Corporation 2 (HSAQ) Financial Analysis & Valuation | Quarter Chart
Health Sciences Acquisitions Corporation 2 (HSAQ)
HSAQPrice: $13.31
Fair Value: 🔒
🔒score
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sec... more
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effec... more
Description
Shares
| Market Cap | $149.23M | Exchange | NASDAQ |
| Sector | Financial Services | Industry | Shell Companies |
| Country | US | CEO | Roderick Tze Ian Wong |
| IPO Date | 2020-08-04 | CAGR | — |
| Employees | — | Website | — |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
HSAQ chart loading...
Fundamentals
Technicals
| Enterprise Value | $494.23M | P/E Ratio | -532.4 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 52.71 | P/B Ratio | 1732.23 |
| P/CF Ratio | -6.23 | P/FCF Ratio | -1.81 |
| EPS | $-0.03 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | -13.58% | Gross Margin | 0.92% |
| Operating Margin | -28.74% | Profit Margin | -28.17% |
| ROE | -3.31% | ROA | -1.86% |
| ROCE | -3.16% | Current Ratio | 2.1 |
| Quick Ratio | 2.09 | Cash Ratio | 1.1 |
| Debt/Equity | 6.68 | Interest Coverage | 30.08 |
| Altman Z Score | -15 | Piotroski Score | 3 |
View Health Sciences Acquisitions Corporation 2 financial charts →